Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
Sign Up to like & getrecommendations! Published in 2019 at "Zeitschrift fur medizinische Physik"
DOI: 10.1016/j.zemedi.2019.11.001
Abstract: Ruthenium-106 ophthalmic applicators have proven to be effective when using beta emitters in brachytherapy. For dose calculations , typically, the dosimetric reference data given by the manufacturer are used. An additional check of the applicators… read more here.
Keywords: ophthalmic applicators; ruthenium 106; 106 ophthalmic; thermoluminescence ... See more keywords
Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas
Sign Up to like & getrecommendations! Published in 2020 at "Acta Oncologica"
DOI: 10.1080/0284186x.2020.1762925
Abstract: Abstract Purpose: Ruthenium-106 (Ru-106) brachytherapy is a common eye-preserving treatment for choroidal melanomas. However, a dose-response model describing the relationship between the actual delivered tumour dose and tumour control has, to the best of our… read more here.
Keywords: dose; control; 106 brachytherapy; ruthenium 106 ... See more keywords
Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma in Sturge-Weber syndrome.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of ophthalmology"
DOI: 10.18240/ijo.2020.03.22
Abstract: AIM To evaluate the efficacy of ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma (DCH) in Sturge-Weber syndrome (SWS). METHODS A total of 8 patients with DCH in SWS managed with plaque brachytherapy… read more here.
Keywords: treatment; ruthenium 106; plaque brachytherapy; 106 plaque ... See more keywords